Biktarvy, formally known as bictegravir sulfate, represents a effective single-tablet therapy for controlling HIV infection. This medication integrates three key antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It works by preventing the virus's ability to multiply within the body, significantly reducing the viral burden.